Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system in the United States. The comp...
Leadership
Douglas G. Cole M.D.Founder
Founder & Independent Chairman of the Board
Adrian H. B. Gottschalk
President, CEO & Director
Steven F. Bellon Ph.D.
Chief Scientific Officer
Alfonso Quintas Cardama M.D.
Chief Medical Officer
Gerald R. Crabtree M.d.Founder
Founder & Member of Scientific Advisory Board
Ryan D. Maynard
Chief Financial Officer
Karin Hellsvik
Chief of Staff to the CEO, VP, Head of Corporate Affairs, Investor Relations & Operations
